Literature DB >> 9152066

Autoimmune retinopathy in the absence of cancer.

J B Mizener1, A E Kimura, G Adamus, C E Thirkill, J A Goeken, R H Kardon.   

Abstract

PURPOSE: To report the clinical and immunologic features of two patients with progressive retinal degeneration and circulating antiretinal antibodies without systemic malignancy.
METHODS: Two patients were followed up for 5 to 7 years. Comprehensive medical and ophthalmic examinations and visual function testing included manual perimetry and standardized electroretinography. Patient sera were tested for antiretinal antibodies by Western blot and immunoperoxidase indirect cytochemistry techniques.
RESULTS: Two patients had family history of autoimmune disease. Each had severe monocular visual loss with photopsia, a ring scotoma, and abnormal electroretinogram despite a normal-appearing ocular fundus. One had a flat electroretinogram; the other had inner retina dysfunction, with selective b wave loss and abnormal oscillatory potentials. Both patients' sera had antiretinal antibodies that specifically labeled the inner plexiform layer of donor retina by indirect immunoperoxidase testing. Neither had any sign of cancer.
CONCLUSIONS: In two patients without systemic malignancy, the symptoms, perimetric findings, and normal fundus appearance resembled cancer associated retinopathy. Electroretinography and antibody findings indicating dysfunction of the inner retina are distinct from those of cancer-associated retinopathy. These two cases raise the possibility of an autoimmune mechanism for retinal degeneration that is not cancer associated. Further study is necessary to determine the role of antiretinal antibodies in these patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9152066     DOI: 10.1016/s0002-9394(14)71073-6

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  23 in total

1.  Coffee and doughnut maculopathy: a cause of acute central ring scotomas.

Authors:  J B Kerrison; S C Pollock; V Biousse; N J Newman
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

2.  Autoantibodies to photoreceptor membrane proteins and outer plexiform layer in patients with cancer-associated retinopathy.

Authors:  R Peek; B G Dijkstra; B Meek; R W A M Kuijpers
Journal:  Clin Exp Immunol       Date:  2002-06       Impact factor: 4.330

3.  Unilateral electronegative ERG of non-vascular aetiology.

Authors:  A G Robson; E C Richardson; A H C Koh; C E Pavesio; P G Hykin; A Calcagni; E M Graham; G E Holder
Journal:  Br J Ophthalmol       Date:  2005-12       Impact factor: 4.638

4.  The approach to bilateral simultaneous isolated optic neuritis.

Authors:  L Frohman
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

Review 5.  The need for standardization of antiretinal antibody detection and measurement.

Authors:  Farzin Forooghian; Ian M Macdonald; John R Heckenlively; Elise Héon; Lynn K Gordon; John J Hooks; Barbara Detrick; Robert B Nussenblatt
Journal:  Am J Ophthalmol       Date:  2008-07-30       Impact factor: 5.258

Review 6.  The enigma of autoimmune retinopathy.

Authors:  Farzin Forooghian; Sijia Cao; Jing Cui; Joanne A Matsubara
Journal:  Int Ophthalmol Clin       Date:  2015

7.  Auto-immune-like cone dystrophy.

Authors:  János Hargitai; Cynthia MacKay; Myles Behrens; Jeffrey G Odel; Donald C Hood; Peter Gouras
Journal:  Doc Ophthalmol       Date:  2004-11       Impact factor: 2.379

8.  Cancer-associated retinopathy caused by benign thymoma.

Authors:  Akiko Tanaka; Hiroshi Takase; Grazyna Adamus; Manabu Mochizuki
Journal:  Br J Ophthalmol       Date:  2010-04       Impact factor: 4.638

Review 9.  Autoimmune retinopathy.

Authors:  Landon Grange; Monica Dalal; Robert B Nussenblatt; H Nida Sen
Journal:  Am J Ophthalmol       Date:  2013-09-29       Impact factor: 5.258

Review 10.  Non-paraneoplastic related retinopathy: clinical challenges and review.

Authors:  Júlia T Takiuti; Vitor K L Takahashi; Christine L Xu; Ruben Jauregui; Stephen H Tsang
Journal:  Ophthalmic Genet       Date:  2019-08-08       Impact factor: 1.803

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.